Mohammad-Salar Hosseini
Overview
Explore the profile of Mohammad-Salar Hosseini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
728
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akbarzadeh M, Vaez-Gharamaleki Y, Hosseini M
Ther Adv Hematol
. 2024 Dec;
15:20406207241306553.
PMID: 39669704
No abstract available.
2.
Banisefid E, Nasiri E, Pourebrahimian Leilabadi S, Hamzehzadeh S, Akbarzadeh M, Hosseini M
Ann Med Surg (Lond)
. 2024 Dec;
86(12):7221-7226.
PMID: 39649904
is a microaerophilic gram-negative bacterium infecting around half of the world's population. Despite its well-known role in gastric malignancies, its impact on esophageal cancer comes with a complex paradox. Several...
3.
Hosseini M, Sanaie S, Mahmoodpoor A, Jabbari Beyrami S, Jabbari Beyrami H, Fattahi S, et al.
Eur J Med Res
. 2024 Nov;
29(1):571.
PMID: 39614391
Xerostomia, generally addressed as dry mouth, poses significant challenges to patients' quality of life, particularly in the context of cancer treatment. Although various medications and interventions, including salivary substitutes and...
4.
Hosseini M, Sanaat Z, Akbarzadeh M, Vaez-Gharamaleki Y, Akbarzadeh M
Eur J Med Res
. 2024 Oct;
29(1):514.
PMID: 39456044
Leukemia remains a major therapeutic challenge in clinical oncology. Despite significant advancements in treatment modalities, leukemia remains a significant cause of morbidity and mortality worldwide, as the current conventional therapies...
5.
Hosseini M
Discov Oncol
. 2024 Oct;
15(1):561.
PMID: 39404911
Li-Fraumeni syndrome is a rare yet serious hereditary cancer predisposition syndrome, marked by a significant early-life increased risk of developing cancer. Primarily caused by germline mutations in the TP53 tumor...
6.
Feizi H, Hosseini M, Seyedi-Sahebari S, Karimi H, Mosaddeghi-Heris R, Sadigh-Eteghad S, et al.
Dement Neuropsychol
. 2024 Sep;
18:e20240147.
PMID: 39258164
Objective: This study aspires to estimate the efficacy and safety of cell-based treatments in AD. Methods: Observing the Joanna Briggs Institute (JBI) methods and Preferred Reporting Items for Systematic Reviews...
7.
Akbarzadeh M, Vaez-Gharamaleki Y, Jahanshahlou F, Bavil A, Hamzehzadeh S, Seifimansour S, et al.
Rev Assoc Med Bras (1992)
. 2024 Aug;
70(8):e20240322.
PMID: 39166680
No abstract available.
8.
9.
Vaez-Gharamaleki Y, Hosseini M
Palliat Support Care
. 2024 May;
:1-2.
PMID: 38736414
No abstract available.
10.
Hosseini M, Jahanshahlou F, Gol Mohammadi Senji A
Int J Surg Open
. 2024 Apr;
:100643.
PMID: 38620106
No abstract available.